1 May 2022 false Taxfiler 2023.12 12561930business:PrivateLimitedCompanyLtd2022-05-012023-04-30 125619302022-04-30 125619302022-05-012023-04-30 12561930business:AuditExemptWithAccountantsReport2022-05-012023-04-30 12561930business:FilletedAccounts2022-05-012023-04-30 125619302023-04-30 12561930business:Director12022-05-012023-04-30 12561930business:RegisteredOffice2022-05-012023-04-30 125619302022-04-30 12561930core:WithinOneYear2023-04-30 12561930core:WithinOneYear2022-04-30 12561930core:ShareCapitalcore:PreviouslyStatedAmount2023-04-30 12561930core:ShareCapitalcore:PreviouslyStatedAmount2022-04-30 12561930core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-04-30 12561930core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-04-30 12561930core:PreviouslyStatedAmount2023-04-30 12561930core:PreviouslyStatedAmount2022-04-30 12561930business:SmallEntities2022-05-012023-04-30 12561930countries:EnglandWales2022-05-012023-04-30 12561930business:OrdinaryShareClass12022-05-012023-04-30 12561930business:OrdinaryShareClass12021-05-012022-04-30 125619302021-05-012022-04-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 12561930 (England and Wales)
Yousef Pharma Ltd Filleted Accounts for the year ended 30 April 2023
Yousef Pharma Ltd Filleted Accounts Contents
Page
- 2 -
Yousef Pharma Ltd Company Information for the year ended 30 April 2023
Director
Yousef Megahed
Company Number
12561930 (England and Wales)
Registered Office
27 Keble Road Leicester LE2 6AF
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
Yousef Pharma Ltd Statement of financial position as at 30 April 2023
2023 
2022 
Notes
£ 
£ 
Current assets
Investments
53,114 
- 
Cash at bank and in hand
45,982 
73,440 
99,096 
73,440 
Creditors: amounts falling due within one year
(39,383)
(45,216)
Net current assets
59,713 
28,224 
Net assets
59,713 
28,224 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
59,613 
28,124 
Shareholders' funds
59,713 
28,224 
For the year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 28 April 2024 and were signed on its behalf by
Yousef Megahed Director Company Registration No. 12561930
- 4 -
Yousef Pharma Ltd Notes to the Accounts for the year ended 30 April 2023
1
Statutory information
Yousef Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 12561930. The registered office is 27 Keble Road, Leicester, LE2 6AF.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
4
Investments held as current assets
2023 
2022 
£ 
£ 
Unlisted investments
53,114 
5
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Taxes and social security
14,006 
5,407 
Other creditors
24,581 
39,049 
Accruals
796 
760 
39,383 
45,216 
- 5 -
Yousef Pharma Ltd Notes to the Accounts for the year ended 30 April 2023
6
Share capital
2023 
2022 
£ 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
100 
7
Average number of employees
During the year the average number of employees was 3 (2022: 2).
- 6 -